Invesco’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.7M Sell
540,229
-246,237
-31% -$22.5M ﹤0.01% 1217
2025
Q4
$102M Buy
786,466
+292,394
+59% +$40.1M 0.01% 826
2025
Q3
$53.2M Sell
494,072
-60,347
-11% -$6.57M 0.01% 1062
2025
Q2
$51.2M Buy
554,419
+164,840
+42% +$12.9M 0.01% 1046
2025
Q1
$34.5M Buy
389,579
+134,228
+53% +$11.6M 0.01% 1178
2024
Q4
$19.6M Buy
255,351
+249,654
+4,382% +$17.4M ﹤0.01% 1499
2024
Q3
$242K Buy
+5,697
New +$192K ﹤0.01% 3474
2023
Q2
Sell
-1,962
Closed -$23.6K 3956
2023
Q1
$23.6K Sell
1,962
-37
-2% -$493 ﹤0.01% 3807
2022
Q4
$17.4K Buy
1,999
+1
+0.1% +$22 ﹤0.01% 3982
2022
Q3
$58K Sell
1,998
-4
-0.2% -$183 ﹤0.01% 3904
2022
Q2
$83K Buy
+2,002
New +$136K ﹤0.01% 3916

Other funds holding WGS

Invesco's WGS Position: Q1 2026 in Review

Invesco reduced its GeneDx Holdings (WGS) stake by 31% in Q1 2026, selling an estimated $22.5M and leaving 540,229 shares worth $34.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1217.

Invesco first reported a position in WGS in Q2 2022 and has held it in 11 quarters since. The position peaked at $102M in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Invesco held 540,229 shares of GeneDx Holdings worth $34.7M as of Q1 2026.
  • Invesco sold 246,237 GeneDx Holdings shares in Q1 2026, an estimated $22.5M.
  • GeneDx Holdings made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #1217 holding.
  • Invesco first reported a position in GeneDx Holdings in Q2 2022 and has held it in 11 quarters since.
  • Invesco's GeneDx Holdings position peaked at $102M in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.